Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Green

Showing results (21-30 of 305) with videos related to

Pageof 31
Sort By:
Frontiers in Cell and Developmental Biology|June 26, 2020
Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer ImmunotherapyDaria S Chulpanova, Kristina V Kitaeva, Andrew R Green, et al.
Breast Cancer Research and Treatment|February 13, 2019
Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancersConstantinos Savva, Karen De Souza, Reem Ali, et al.
Oncotarget|October 30, 2015
Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinomaArvydas Laurinavicius, Andrew R Green, Aida Laurinaviciene, et al.
The Journal of Physical Chemistry. B|May 9, 2019
Investigation of the Amide Proton Solvent Exchange Properties of Glycosaminoglycan OligosaccharidesAndrew R Green, Kecheng Li, Blake Lockard, et al.
Cancers|January 31, 2019
Liver Kinase B1-A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older WomenBinafsha Manzoor Syed, Andrew R Green, David A L Morgan, et al.
International Journal of Molecular Sciences|March 28, 2026
Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast CancerBrendah K Masisi, Rokaya El Ansari, Ali Fakroun, et al.
Journal of Cellular and Molecular Medicine|May 1, 2020
Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancerBehnaz Saidy, Emad A Rakha, Andrew R Green, et al.
Histopathology|August 28, 2022
Refining the definition of HER2-low class in invasive breast cancerNehal M Atallah, Michael S Toss, Andrew R Green, et al.
Breast Cancer Research and Treatment|April 15, 2010
CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosisAbdulkader Albasri, Mohammed Aleskandarany, Ahmed Benhasouna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2023
Novel 2 Gene Signatures Associated With Breast Cancer Proliferation: Insights From Predictive Differential Gene Expression AnalysisAsmaa Ibrahim, Michael S Toss, Mansour Alsaleem, et al.
Pageof 31

Showing results (21-30 of 305) with videos related to

Sort By:
Pageof 31
Frontiers in Cell and Developmental Biology|June 26, 2020
Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer ImmunotherapyDaria S Chulpanova, Kristina V Kitaeva, Andrew R Green, et al.
Breast Cancer Research and Treatment|February 13, 2019
Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancersConstantinos Savva, Karen De Souza, Reem Ali, et al.
Oncotarget|October 30, 2015
Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinomaArvydas Laurinavicius, Andrew R Green, Aida Laurinaviciene, et al.
The Journal of Physical Chemistry. B|May 9, 2019
Investigation of the Amide Proton Solvent Exchange Properties of Glycosaminoglycan OligosaccharidesAndrew R Green, Kecheng Li, Blake Lockard, et al.
Cancers|January 31, 2019
Liver Kinase B1-A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older WomenBinafsha Manzoor Syed, Andrew R Green, David A L Morgan, et al.
International Journal of Molecular Sciences|March 28, 2026
Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast CancerBrendah K Masisi, Rokaya El Ansari, Ali Fakroun, et al.
Journal of Cellular and Molecular Medicine|May 1, 2020
Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancerBehnaz Saidy, Emad A Rakha, Andrew R Green, et al.
Histopathology|August 28, 2022
Refining the definition of HER2-low class in invasive breast cancerNehal M Atallah, Michael S Toss, Andrew R Green, et al.
Breast Cancer Research and Treatment|April 15, 2010
CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosisAbdulkader Albasri, Mohammed Aleskandarany, Ahmed Benhasouna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2023
Novel 2 Gene Signatures Associated With Breast Cancer Proliferation: Insights From Predictive Differential Gene Expression AnalysisAsmaa Ibrahim, Michael S Toss, Mansour Alsaleem, et al.
Pageof 31